SCHEMBL6964612

SCHEMBL6964612

COC/C=C\C1CCCCC1

nearest known ligand 0.39

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CACNA1B Q00975 1/20 0.33
NPSR1 Q6W5P4 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14527716 1.00 CACNA1B (0.33) CACNA1BNPSR1
SCHEMBL6960090 1.00 CACNA1B (0.33) CACNA1BNPSR1
SCHEMBL17039350 0.98 CACNA1B (0.32) CACNA1B
SCHEMBL17039354 0.93
SCHEMBL17039353 0.88
SCHEMBL17039473 0.78
SCHEMBL20730464 0.77 SHBG (0.31)
SCHEMBL17036750 0.77
SCHEMBL8909887 0.76 NPSR1 (0.32) NPSR1
SCHEMBL13845702 0.75 TEAD2 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0891331-B1 N-(2 OXOACETYL OR SULPHONYL)-PYRROLIDINE/PIPERIDINE-2-CARBOXYLIC ACID DERIVATIVES WITH IMPROVED MULTI-DRUG RESISTANCE ACTIVITY VERTEX PHARMA (US) 2003-10-01 EP disclosed